• Explore /
  • Poster
  • / Plasma VEGF-A (pVEGF-A) level in efficacy analysis of metastatic colorectal cancer patients (mCRC) treated with mFOLFOX6/XELOX plus bevacizumab (BV) (WJOG7612GTR).

Plasma VEGF-A (pVEGF-A) level in efficacy analysis of metastatic colorectal cancer patients (mCRC) treated with mFOLFOX6/XELOX plus bevacizumab (BV) (WJOG7612GTR).

Abstract Poster

Authors

null

Wataru Okamoto

National Cancer Center, Kashiwa, Japan

Wataru Okamoto , Akitaka Makiyama , Yoshiyuki Yamamoto , Kohei Shitara , Tadamichi Denda , Naoki Izawa , Yasuyuki Nakano , Tomohiro Nishina , Taito Esaki , Hiroki Hara , Yukinori Ozaki , Hiroyuki Okuda , Narikazu Boku , Ichinosuke Hyodo , Kentaro Yamazaki , Shuichi Hironaka , Kazuko Sakai , Takeharu Yamanaka , Kei Muro , Kazuto Nishio

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

UMIN000012442

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 699)

DOI

10.1200/JCO.2018.36.4_suppl.699

Abstract #

699

Poster Bd #

G12

Abstract Disclosures

Similar Posters

First Author: Yoshiyuki Yamamoto

First Author: Kathrin Heinrich

First Author: Hiroyuki Arai

First Author: Marc Peeters